7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Teaching the basics of cancer metabolism: Developing antitumor strategies by exploiting the differences between normal and cancer cell metabolism

      review-article
      Redox Biology
      Elsevier
      ATP, adenosine triphosphate, BrP, bromopyruvate, CO2, carbon dioxide, CoA, acetyl-coenzyme A, 2-DG, 2-deoxyglucose, ETC, electron transport chain, FAO, fatty acid oxidation, FAD, flavin adenine dinucleotide, FDG, fluorinated deoxyglucose, FFA, free fatty acid, GAPDH, glyceraldehyde-3-phosphate, GIAN, Global Initiative of Academic Networks, G-6P, glucose-6-phosphate, GLUT, glucose transporters, H2O, water, HK, hexokinase, HIF-1, hypoxia-inducible factor 1, IDH-2, isocitrate dehydrogenase-2, KRAS, V-Ki-ras2 Kirsten rat sarcoma, LDH, lactate dehydrogenase, LN, lonidamine, MAGL, monoacylglycerol lipase, MCT, monocarboxylate transporter, MDR, multidrug resistance, NAD+, nicotinamide adenine dinucleotide, NADPH, nicotinamide adenine dinucleotide phosphate, OXPHOS, oxidative phosphorylation, FAO, fatty acid oxidation, PDH, pyruvate dehydrogenase, PDK, pyruvate dehydrogenase kinase, IDH-2, isocitrate dehydrogenase-2, PK, pyruvate kinase, TCA, tricarboxylic acid, TPP+, triphenylphosphonium, VDAC, voltage-dependent anion channel

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This review of the basics of cancer metabolism focuses on exploiting the metabolic differences between normal and cancer cells. The first part of the review covers the different metabolic pathways utilized in normal cells to generate cellular energy, or ATP, and the glycolytic intermediates required to build the cellular machinery. The second part of the review discusses aerobic glycolysis, or the Warburg effect, and the metabolic reprogramming involving glycolysis, tricarboxylic acid cycle, and glutaminolysis in the context of developing targeted inhibitors in cancer cells. Finally, the selective targeting of cancer mitochondrial metabolism using positively charged lipophilic compounds as potential therapeutics and their ability to mitigate the toxic side effects of conventional chemotherapeutics in normal cells are discussed. I hope this graphical review will be useful in helping undergraduate, graduate, and medical students understand how investigating the basics of cancer cell metabolism could provide new insight in developing potentially new anticancer treatment strategies.

          Highlights

          • Exploiting biochemical and metabolic differences between normal and cancer cells.

          • Mitigating reverse Warburg effect in the tumor stroma or microenvironment to hinder tumor growth.

          • Dual targeting of glycolysis and mitochondrial metabolism to inhibit tumor cell proliferation.

          Related collections

          Most cited references56

          • Record: found
          • Abstract: not found
          • Article: not found

          On the origin of cancer cells.

          O WARBURG (1956)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Targeting antioxidants to mitochondria by conjugation to lipophilic cations.

            Mitochondrial oxidative damage contributes to a range of degenerative diseases. Consequently, the selective inhibition of mitochondrial oxidative damage is a promising therapeutic strategy. One way to do this is to invent antioxidants that are selectively accumulated into mitochondria within patients. Such mitochondria-targeted antioxidants have been developed by conjugating the lipophilic triphenylphosphonium cation to an antioxidant moiety, such as ubiquinol or alpha-tocopherol. These compounds pass easily through all biological membranes, including the blood-brain barrier, and into muscle cells and thus reach those tissues most affected by mitochondrial oxidative damage. Furthermore, because of their positive charge they are accumulated several-hundredfold within mitochondria driven by the membrane potential, enhancing the protection of mitochondria from oxidative damage. These compounds protect mitochondria from damage following oral delivery and may therefore form the basis for mitochondria-protective therapies. Here we review the background and work to date on this class of mitochondria-targeted antioxidants.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer

              The unique metabolism of most solid tumours (aerobic glycolysis, i.e., Warburg effect) is not only the basis of diagnosing cancer with metabolic imaging but might also be associated with the resistance to apoptosis that characterises cancer. The glycolytic phenotype in cancer appears to be the common denominator of diverse molecular abnormalities in cancer and may be associated with a (potentially reversible) suppression of mitochondrial function. The generic drug dichloroacetate is an orally available small molecule that, by inhibiting the pyruvate dehydrogenase kinase, increases the flux of pyruvate into the mitochondria, promoting glucose oxidation over glycolysis. This reverses the suppressed mitochondrial apoptosis in cancer and results in suppression of tumour growth in vitro and in vivo. Here, we review the scientific and clinical rationale supporting the rapid translation of this promising metabolic modulator in early-phase cancer clinical trials.
                Bookmark

                Author and article information

                Contributors
                Journal
                Redox Biol
                Redox Biol
                Redox Biology
                Elsevier
                2213-2317
                13 April 2017
                August 2017
                13 April 2017
                : 12
                : 833-842
                Affiliations
                [0005]Department of Biophysics and Free Radical Research Center, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, USA
                Article
                S2213-2317(17)30138-6
                10.1016/j.redox.2017.04.018
                5406543
                28448945
                613ab309-b5c5-498b-8a8a-9dc80a17e7b2
                © 2017 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 21 February 2017
                : 7 April 2017
                : 10 April 2017
                Categories
                Review Article

                atp, adenosine triphosphate,brp, bromopyruvate,co2, carbon dioxide,coa, acetyl-coenzyme a,2-dg, 2-deoxyglucose,etc, electron transport chain,fao, fatty acid oxidation,fad, flavin adenine dinucleotide,fdg, fluorinated deoxyglucose,ffa, free fatty acid,gapdh, glyceraldehyde-3-phosphate,gian, global initiative of academic networks,g-6p, glucose-6-phosphate,glut, glucose transporters,h2o, water,hk, hexokinase,hif-1, hypoxia-inducible factor 1,idh-2, isocitrate dehydrogenase-2,kras, v-ki-ras2 kirsten rat sarcoma,ldh, lactate dehydrogenase,ln, lonidamine,magl, monoacylglycerol lipase,mct, monocarboxylate transporter,mdr, multidrug resistance,nad+, nicotinamide adenine dinucleotide,nadph, nicotinamide adenine dinucleotide phosphate,oxphos, oxidative phosphorylation,pdh, pyruvate dehydrogenase,pdk, pyruvate dehydrogenase kinase,pk, pyruvate kinase,tca, tricarboxylic acid,tpp+, triphenylphosphonium,vdac, voltage-dependent anion channel

                Comments

                Comment on this article